Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Daxor Corporation

Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
Daxor Corporation Announces Launch of Proposed Underwritten Public Offering
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100®) to Improve Heart Failure Outcomes and Reduce Costs
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Evaluation of Heart Failure
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
DAXOR CORPORATION TO EXHIBIT AND PRESENT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’22 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
Study Data from Mayo Clinic on Heart Failure Treatment Effectiveness Utilizing Daxor BVA-100 Presented at Key Scientific Meeting
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100® Lowers Hospital Length of Stay by 55%
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
New Studies Validating the Uniqueness of the BVA-100® Blood Test for Heart Failure Patients Compared to Pressure Measures
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.
From Daxor Corporation
Via GlobeNewswire
Tickers DXR
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.